Tianyu Pharma

Founded in 1993, Tianyu Pharma is a modern pharmaceutical company dedicated to the research, development, production, and sales of advanced pharmaceutical intermediates, specialty APIs, and formulation products. The company has established itself as a world-leading supplier for chronic disease and anti-cancer drugs. Its extensive product portfolio targets critical therapeutic areas, demonstrating a commitment to addressing significant global health challenges through innovative pharmaceutical solutions.

Tianyu Pharma's major product lines encompass treatments for blood pressure-lowering, blood glucose-lowering, lipid-lowering, anti-thrombotic, and anti-asthma conditions. The company offers comprehensive one-stop services, supporting clients from clinical phase I through to commercial production for both originator and generic pharmaceutical companies worldwide. Operating with a workforce of 1,000-5,000 employees, Tianyu Pharma leverages its expertise to deliver high-quality pharmaceutical services and products. Meet Tianyu Pharma's team to understand the driving force behind their operations.

With a reported revenue of $6.7B and a single primary location, Tianyu Pharma operates within the Pharmaceuticals and Healthcare industries. The company's market presence is further indicated by hashtags such as #5_plus_marketing, #china, #founded_1993, #b2b, #asiapacific, and #asia. Trading under the ticker SSE: 300702, Tianyu Pharma focuses on delivering advanced pharmaceutical solutions globally, reinforcing its position as a key player in specialized drug development and manufacturing.